Trial to assess whether once‑weekly treatment can reduce symptomatic viral respiratory infections
Category: News
siRNA therapeutic progresses in global study for patients with elevated Lp(a)
Company strengthens pipeline with AKTX-102 as it broadens its intellectual property estate
Initiative focuses on population-specific molecular profiling
Company strengthens its neuropsychiatry portfolio after marketing transfer from Recordati
Dawnzera showed an 81% reduction in the four-weekly rate of HAE attacks compared to placebo
Ovarian cancer is the fifth leading cause of deaths from cancer in women
The vaccine could be created as a ready-to-use product, rather than needing to be personalised
The PM Awards celebrate creativity in pharmaceutical marketing and healthcare communications
More than 71% of patients treated with Unloxcyt achieved disease control